Azacitidine

Azacytidine

ONUREG VIDAZA

Therapeutic Indications

Azacitidine is indicated for:

at least one of

Acute myeloid leukaemia

Chronic myelomonocytic leukemia, Type II

Myelodysplastic syndromes

For this indication, the medical literature mentions below treatments (click for details):

Active ingredient Azacitidine is contraindicated in the following cases:

No gender/age discrimination

at least one of

Pregnancy

Lactation

Malignant neoplasm of liver and intrahepatic bile ducts

Secondary malignant neoplasm of liver

Next: Precautions >